CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

Recruiting

Phase 1

Phase 2

CMVIGCMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

Sponsor:

University of Minnesota

Code:

NCT07096453

Conditions

Kidney Transplant; Complications

CMV

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Cytogam

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by University of Minnesota on 2025-10-31.